TRAF inhibition drives cancer cell apoptosis and improves retinoic acid sensitivity in multiple cancers models
Kun Zhong1, Xiaojun Liu1, Weihua Ding1
1Medical School, Nantong University, 19 Qixiu Road, Nantong, 226001, Jiangsu Province, People's Republic of China.
Abstract:
TNF receptor-associated factors (TRAFs) are signaling adaptor proteins that play a crucial role in regulating cellular receptors' signaling transduction to downstream pathways and exert multifaceted roles in regulating signaling pathways, cell survival, and carcinogenesis. The 13-cis-retinoic acid (RA), an active metabolite of vitamin A, exhibits anti-cancer properties, but the development of retinoic acid resistance poses a challenge in clinical application. This study aimed to investigate the relationship between TRAFs and retinoic acid sensitivity in various cancers. Here, we revealed that TRAFs' expression varied significantly across The Cancer Genome Atlas (TCGA) cancer cohorts and human cancer cell lines. Additionally, inhibiting TRAF4, TRAF5, or TRAF6 improved retinoic acid sensitivity and reduced colony formation in ovarian cancer and melanoma cells. Mechanistically, knocking down TRAF4, TRAF5, or TRAF6 in retinoic acid-treated cancer cell lines increased the levels of procaspase 9 and induced cell apoptosis. Further in vivo studies using the SK-OV-3 and MeWo xenograft models confirmed the anti-tumor effects of TRAF knockdown combined with retinoic acid treatment. These findings support that combination therapy with retinoic acid and TRAF silencing may offer significant therapeutic advantages in treating melanoma and ovarian cancers.
Insights
This study shows that inhibiting TNF receptor-associated factors (TRAFs) enhances cancer cells
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- TNF receptor-associated factors (TRAFs) are key signaling adaptors involved in cellular pathways, survival, and cancer.
- 13-cis-retinoic acid (RA), a vitamin A metabolite, has anti-cancer effects, but resistance limits its clinical use.
- Understanding factors influencing RA sensitivity is crucial for improving cancer therapy.
Purpose of the Study:
- To investigate the association between TRAF expression and retinoic acid sensitivity in various cancers.
- To explore the therapeutic potential of combining RA with TRAF inhibition.
Main Methods:
- Analyzed TRAF expression across TCGA cancer cohorts and cell lines.
- Inhibited TRAF4, TRAF5, or TRAF6 in ovarian cancer and melanoma cell lines and xenografts.
- Assessed effects on RA sensitivity, colony formation, apoptosis (procaspase 9 levels), and in vivo tumor growth.
Main Results:
- TRAF expression levels differed significantly across cancer types.
- Inhibiting TRAF4, TRAF5, or TRAF6 enhanced RA sensitivity and reduced colony formation in ovarian cancer and melanoma.
- TRAF knockdown increased procaspase 9 and induced apoptosis in RA-treated cancer cells, with confirmed anti-tumor effects in vivo.
Conclusions:
- TRAF proteins are linked to retinoic acid resistance in cancers.
- Silencing TRAF4, TRAF5, or TRAF6 potentiates the anti-cancer effects of retinoic acid.
- Combination therapy with retinoic acid and TRAF silencing shows promise for treating ovarian cancer and melanoma.
More Related Videos
09:04Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
Published on: April 22, 2017
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Extrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibition of Cdk Activity
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
